Dennis Slater

1.2k total citations
15 papers, 178 citations indexed

About

Dennis Slater is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Dennis Slater has authored 15 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Dennis Slater's work include Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Dennis Slater is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Dennis Slater collaborates with scholars based in United States and Canada. Dennis Slater's co-authors include Sanford Kempin, Arlin Za, Peter Schauer, Susan McKenzie, Toby Gee, Benjamín Koziner, David J. Straus, R Mertelsmann, Bernard R. Greenberg and Antônio C. Buzaid and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Thrombosis and Haemostasis.

In The Last Decade

Dennis Slater

14 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis Slater United States	5	81	53	41	35	33	15	178
Andrew Aw Canada	9	106 1.3×	38 0.7×	59 1.4×	144 4.1×	17 0.5×	21	272
Ondřej Zapletal Czechia	8	18 0.2×	10 0.2×	86 2.1×	12 0.3×	50 1.5×	34	233
M. Simon Germany	6	61 0.8×	64 1.2×	14 0.3×	25 0.7×	49 1.5×	19	202
Zdravko Mitrović Croatia	10	160 2.0×	117 2.2×	4 0.1×	95 2.7×	8 0.2×	30	255
Avyakta Kallam United States	9	102 1.3×	104 2.0×	7 0.2×	66 1.9×	24 0.7×	52	249
Elisabetta Nobili Italy	9	21 0.3×	167 3.2×	4 0.1×	14 0.4×	24 0.7×	25	260
Chong Chyn Chua Australia	10	11 0.1×	49 0.9×	32 0.8×	82 2.3×	9 0.3×	37	341
Ayumi Shikama Japan	11	65 0.8×	90 1.7×	46 1.1×	5 0.1×	33 1.0×	33	318
Simon Soudet France	8	9 0.1×	36 0.7×	41 1.0×	43 1.2×	60 1.8×	27	235
Rowan G. Doig Australia	7	13 0.2×	43 0.8×	98 2.4×	56 1.6×	24 0.7×	11	297

Countries citing papers authored by Dennis Slater

Since Specialization

Citations

This map shows the geographic impact of Dennis Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Slater more than expected).

Fields of papers citing papers by Dennis Slater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Slater. The network helps show where Dennis Slater may publish in the future.

Co-authorship network of co-authors of Dennis Slater

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Slater. A scholar is included among the top collaborators of Dennis Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Slater. Dennis Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Stricker, Thomas, Esprit Ma, Elaine Yu, et al.. (2024). Clinical Value of Timely Targeted Therapy for Patients With Advanced Non–Small Cell Lung Cancer With Actionable Driver Oncogenes. The Oncologist. 29(6). 534–542. 4 indexed citations

Stricker, Thomas, Elaine Yu, Esprit Ma, et al.. (2023). Clinical value of timely targeted therapy (TT) for patients with advanced non-small cell lung cancer (aNSCLC) with actionable driver oncogenes (ADO).. Journal of Clinical Oncology. 41(16_suppl). 6507–6507. 1 indexed citations

Schwartzberg, Lee S., Davey B. Daniel, Daniel A. Vaena, et al.. (2023). Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA. Future Oncology. 19(20). 1397–1414.

Schwartzberg, Lee S., Craig S. Meyer, Anuj Shah, et al.. (2022). Evolution of biomarker testing in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC) in U.S. community practices.. Journal of Clinical Oncology. 40(16_suppl). e18778–e18778. 2 indexed citations

Mohammed, Turab, et al.. (2021). Doege-Potter Syndrome with a Benign Solitary Fibrous Tumor: A Case Report and Literature Review. Case Reports in Oncology. 14(1). 470–476. 14 indexed citations

Vanderwalde, Ari M., Esprit Ma, Elaine Yu, et al.. (2021). NGS testing patterns in advanced non-small cell lung cancer (aNSCLC) and metastatic breast cancer (mBC): OneOncology (OO) sites compared to Flatiron Health Nationwide (NAT).. Journal of Clinical Oncology. 39(28_suppl). 288–288. 3 indexed citations

Vanderwalde, Ari M., Esprit Ma, Elaine Yu, et al.. (2021). Biomarker testing patterns and actionability in advanced non-small cell lung cancer (aNSCLC) at OneOncology (OneOnc).. Journal of Clinical Oncology. 39(28_suppl). 287–287. 1 indexed citations

Kearon, Clive, Chu‐Shu Gu, Jim A. Julian, et al.. (2019). Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial. Thrombosis and Haemostasis. 119(4). 633–644. 41 indexed citations

Overton, Lindsay, Christopher L. Corless, Manish Agrawal, et al.. (2014). Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.. Journal of Clinical Oncology. 32(15_suppl). 11028–11028. 1 indexed citations

10.

Johnson, Susan E., et al.. (2010). aPTT Versus Anti Xa Monitoring of Unfractionated Heparin - a Retrospective Review of Clinical Outcomes. Blood. 116(21). 4391–4391. 1 indexed citations

11.

Slater, Dennis. (2005). Histologic Diagnosis of Inflammatory Skin Diseases. An Algorithmic Method Based on Pattern Analysis, 3rd edn. Histopathology. 47(6). 641–642. 6 indexed citations

12.

Sporn, Jonathan, et al.. (1997). Treatment of Advanced Pancreatic Adenocarcinoma with 5-FU, Leucovorin, Interferon-α-2b, and Cisplatin. American Journal of Clinical Oncology. 20(1). 81–83. 13 indexed citations

13.

Slater, Dennis. (1995). L'entreposage visible: l'expérience de Glenbow. Museum International (Edition Francaise). 47(4). 13–17. 1 indexed citations

14.

Slater, Dennis, R Mertelsmann, Benjamín Koziner, et al.. (1986). Lymphoblastic lymphoma in adults.. Journal of Clinical Oncology. 4(1). 57–67. 87 indexed citations

15.

Zachary, Christopher B., et al.. (1983). The nature of amiodarone photosensitivity and pigmentation. British Journal of Dermatology. 109(s24). 35–36. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact